Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02708511 · ClinicalTrials.gov registry record · Phase 1
Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer
A Phase 1 study, sponsored by Sanjiv Sam Gambhir.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT02708511: Clinical Trial Phase 1 study, sponsored by Sanjiv Sam Gambhir.
NCT02708511 is a Phase 1 study that was terminated before completion, run by Sanjiv Sam Gambhir. The registered enrollment target is 2 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02708511, a Phase 1 study, was terminated before completion, sponsored by Sanjiv Sam Gambhir.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This pilot clinical trial studies copper Cu 64-DOTA-B-Fab positron emission tomography (PET)/computed tomography (CT) in imaging patients with ovarian and breast cancer. Cancer antigen (CA)6 is an antigen (substance) found on the surface of several types of cancer cells such as cancer of the ovary and breast. Diagnostic procedures, such as copper Cu 64-DOTA-B-Fab PET/CT, may help identify CA6 positive tumors and allow doctors to plan better treatment.
Primary Outcome
Determined from serial imaging correlated with blood and urine samples.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Pharmacological Study
- DIAGNOSTIC_TEST Computed Tomography
- DIAGNOSTIC_TEST Positron Emission Tomography
- DRUG Copper Cu 64-DOTA B-Fab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-10-11 |
| Phase | Phase 1 |
Why NCT02708511 stopped before completion
NCT02708511 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02708511 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02708511 about?
NCT02708511 is a clinical study titled "Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer". This pilot clinical trial studies copper Cu 64-DOTA-B-Fab positron emission tomography (PET)/computed tomography (CT) in imaging patients with ovarian and breast cancer. Cancer antigen (CA)6 is an antigen (substance) found on the surface of several types of cancer cells such as cancer of the ovary a...
What is the current status of trial NCT02708511?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2016-08. Estimated completion is 2017-10-11.
What interventions are being tested in trial NCT02708511?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Pharmacological Study (OTHER), Computed Tomography (DIAGNOSTIC_TEST), Positron Emission Tomography (DIAGNOSTIC_TEST), Copper Cu 64-DOTA B-Fab (DRUG).
Who is sponsoring clinical trial NCT02708511?
This trial is sponsored by Sanjiv Sam Gambhir, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02708511's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia